Samotolisib
CAS: 1386874-06-1
Ref. TM-T6883
| 1mg | 35.00 € | ||
| 2mg | 52.00 € | ||
| 5mg | 74.00 € | ||
| 10mg | 113.00 € | ||
| 25mg | 240.00 € | ||
| 50mg | 421.00 € | ||
| 100mg | 616.00 € | ||
| 1ml*10 (DMSO) | 84.00 € |
Estimated delivery in United States, on Monday 13 May 2024
Product Information
Name:
Samotolisib
Synonyms:
- GTPL8918, LY3023414
CAS:
Description:
Samotolisib (LY3023414) is an oral ATP competitive inhibitor of the class I PI3K isoforms, DNA-PK, and mTOR. Samotolisib (LY3023414) has been used in trials studying the treatment of Neoplasm, Solid Tumor, COLON CANCER, BREAST CANCER, and Advanced Cancer, among others.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
406.48
Formula:
C23H26N4O3
Purity:
99.71%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T6883 Samotolisib
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
